Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.

× No keyword cloud information.

11 in total

1. The UKPDS: what was the question?

Authors: R M Ewart
Journal: Lancet Date: 1999-05-29 Impact factor: 79.321

2. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors: L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal: Lancet Date: 1999-02-20 Impact factor: 79.321

3. Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.

Authors: D M Nathan
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

4. The UK Prospective Diabetes Study.

Authors: W Kerner
Journal: Lancet Date: 1998-12-12 Impact factor: 79.321

5. The UK Prospective Diabetes Study.

Authors: C J Bailey; P J Grant
Journal: Lancet Date: 1998-12-12 Impact factor: 79.321

Review 6. How to read a paper. Papers that report drug trials.

Authors: T Greenhalgh
Journal: BMJ Date: 1997-08-23

7. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

Authors: C L Meinert; G L Knatterud; T E Prout; C R Klimt
Journal: Diabetes Date: 1970 Impact factor: 9.461

8. The number needed to treat: a clinically useful measure of treatment effect.

Authors: R J Cook; D L Sackett
Journal: BMJ Date: 1995-02-18

9. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors:
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors:
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

27 in total

1. Seeing what you want to see in randomised controlled trials. Authors' choice of study was ill informed.

Authors: R Holman
Journal: BMJ Date: 2000-10-28

2. Complexity, leadership, and management in healthcare organisations.

Authors: P E Plsek; T Wilson
Journal: BMJ Date: 2001-09-29

3. Glycaemia and vascular effects of type 2 diabetes. Lowering glucose concentrations may not be of any value in itself.

Authors: B Budenholzer
Journal: BMJ Date: 2001-05-19

4. Why were the benefits of tPA exaggerated?

Authors: Griffin Trotter
Journal: West J Med Date: 2002-05

5. Interpretation of randomised trials is indeed open to debate.

Authors: Philipp Conradi; David Taylor
Journal: BMJ Date: 2003-09-27

Review 6. Metformin's contraindications should be contraindicated.

Authors: James McCormack; Kevin Johns; Hugh Tildesley
Journal: CMAJ Date: 2005-08-30 Impact factor: 8.262

7. [Irrelevant research in primary care? Is clinical research used to generate evidence from practice?].

Authors: J L Turabián Fernández; B Pérez Franco
Journal: Aten Primaria Date: 2003 Impact factor: 1.137

8. Managing hyperglycaemia.

Authors: Simon Curtis
Journal: Br J Gen Pract Date: 2008-10 Impact factor: 5.386

Review 9. Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50.

Authors: Simon B Dimmitt; Hans G Stampfer; Jennifer H Martin; Robin E Ferner
Journal: Br J Clin Pharmacol Date: 2019-08-19 Impact factor: 4.335

10. Doctor's Dilemma.

Authors: B M Hegde
Journal: Med J Armed Forces India Date: 2011-07-21